Arellano, Gabriel
Acuña, Eric
Loda, Eileah
Moore, Lindsay
Tichauer, Juan E.
Castillo, Cristian
Vergara, Fabian
Burgos, Paula I.
Penaloza-MacMaster, Pablo
Miller, Stephen D.
Naves, Rodrigo
Funding for this research was provided by:
Agencia Nacional de Investigación y Desarrollo (National Doctoral scholarship CONICYT-CHILE 21130452, FONDECYT/ANID postdoc 3150133, FONDECYT/ANID 1141211, FONDECYT/ANID 1140049)
MECESUP Chile (UCH 1304)
National Institute on Drug Abuse (DP2DA051912)
Johnnie Walkers MS Foundation
Amy and David Fulton Foundation
Crammer Family Foundation
Thomas and Deige McLaughlin Foundation
Rottering Family Foundation
Article History
Received: 26 March 2024
Accepted: 5 May 2024
First Online: 31 May 2024
Declarations
:
: All animal experiments and procedures were conducted in accordance with the Institutional Animal Care and Use guidelines (IACUC) of the Universidad de Chile and Northwestern University.
: SDM is a co-founder, paid consultant, scientific advisory board member, and grantee of COUR Pharmaceuticals. SDM is also a consultant for NextCure and Takeda Pharmaceuticals. The other authors have declared that no conflicts of interest exist.